An investigation is under way into the causes of death of two men in New South Wales, Australia, who died a few days after receiving their vaccines for COVID-19.
Fifty-five died at a hospital in northeastern New South Wales on April 21 from a pulmonary embolism eight days after being vaccinated. There is no indication that he was already suffering from a lung disease, as broadcast by AMPE.
At this stage It has not been confirmed which vaccine was given to the 55-year-old, according to the local network 7NEWS.
The Australian Therapeutic Goods Administration (TGA) has stated that in all cases where “death after vaccination is reported, the data are examined to assess the likelihood that the vaccine may have contributed to the event or to the fatal condition” .
The second man, 71 years old, who had multiple underlying diseases, died in Sydney after vaccination with the AstraZeneca product. In this case, too, the TGA is conducting an investigation to determine if the vaccine is associated with death.
The TGA has concluded that there may be a link between the AstraZeneca vaccine and the death of a 48-year-old New South Wales woman in hospital from a thromboembolic event one day after she was vaccinated.
Three other cases of extremely rare blood clots – they are a 35-year-old, a 49-year-old and an 80-year-old – it is considered that they were also connected with AstraZeneca vaccine.
“All three patients are being treated in a stable clinical condition, have had a good response to the treatment given to them and are recovering,” according to the TGA.
Its principles Australia decided to give the AstraZeneca vaccine to people over the age of 50 and the Pfizer / BioNTech vaccine to younger people.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
